New Delhi [India], April 7 (ANI): Calling it an immediate priority, the National Task Force for COVID-19 has recommended establishing the "India COVID-19 Clinical Research Collaborative Network."
This will be coordinated by the Indian Council of Medical Research (ICMR). The goal of this network is to enhance the clinical understanding of COVID-19 in the country so as to develop specific clinical management protocols and further research and development (R & D) for therapeutics.
For this purpose, a central database of clinical and laboratory parameters of hospitalised COVID-19 cases is being created. All hospitals currently managing COVID-19 patients are invited to become partners in the network.
Meanwhile, hospitals should continue to independently report the concerned data to Central/State health authorities as per the current guidelines, according to the ICMR.
In a letter, Dr Balram Bhargava, Director General of ICMR, said: "The national task force for COVID-19 has constituted the research groups to identify the research priorities and quickly initiate research studies. This group includes clinical research group, research on diagnostics and biomarkers, epidemiology and surveillance, operations research, vaccine/drug research, and development."
The chairs of these groups will convene meetings of respective groups through video conference to identify research priorities, develop research protocols and identify partners institutes for initiating studies, Dr Bhargava said in the letter, a copy of which is with ANI.
The letter discussed the TOR for each group which has a focus to -- identify research priorities, review evidence, align them in consonance with the current level of response, identify protocols and partners for implementation.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
